REGULATORY INTELLIGENCE·Recall
Safecor Health Initiates Class II Recall of Haloperidol Lactate Due to RFID Tag Mislabeling
Safecor Health, LLC has initiated a Class II recall for Haloperidol Lactate Injection due to incorrect RFID tag labels applied by the repackaging firm. This incident, impacting 800 vials distributed in Massachusetts, highlights critical vulnerabilities in third-party labeling processes, demanding immediate review by procurement and regulatory teams to mitigate supply chain risks and ensure patient safety.
90-Day Activity